chA-21

N/A

Report date: 2025/02/01 20:00:06

Base Information

Drug NamechA-21
Drug Alias Nameanti-p185 HER2 mAb (Anhui Anke Biotechnology/University of Science and Technology of China)ErbB2 (University of Science and Technology of China)ErbB2 inhibitor (Anhui Anke Biotechnology)
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Chimeric monoclonal antibody
Mechanisms of ActionReceptor protein-tyrosine kinase erbB-2 antagonists
TargetsReceptor protein-tyrosine kinase erbB-2
Therapy Area/IndicationsStomach NeoplasmsBreast Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaPending
Originator CompaniesUniversity Of Science And Technology Of China
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesUniversity Of Science And Technology Of ChinaAnhui Anke Biotechnology (Group) Co Ltd
Active IndicationsN/A
Inactive IndicationsStomach NeoplasmsBreast Neoplasms

Other Information

ATC CodeN/A
Related LinksN/A